Address: Actavis Ireland, Euro House,Euro Business Park, Little Island, Cork ,Ireland
Tel: 021 4619040
Web: http://www.actavis.ie/en/default.htm
Actavis is one of the world’s leading players in the development, manufacture, and sale of First-Class Generic Pharmaceuticals.
Actavis has more than 10,000 employees operating in about 40 countries around the globe.
Actavis has one of the broadest product portfolios and pipelines in the industry, with over 830 medicines available and more than 350 in development.
As part of the larger group, Actavis Ireland is committed to providing first class generics on Day One of Patent Expiry, as well as supporting pharmacists through a series of training and education initiatives.
We consistently offer customers high levels of service, with a Sales & Marketing team who are experts in the field of Generic Pharmaceuticals.
Located in Little Island, Cork, Actavis Ireland is dedicated to serving the needs of Irish Healthcare professionals.
Within their product range we carry a large portfolio of products ranging from Hospital Specific, to Prescription and OTC. Their broad portfolio allows them to provide even greater choice for patients by placing pharmacists at the heart of healthcare provision.
Mr. Hynds, you were personally instrumental in leading the establishment of Actavis in Ireland in 2008. You commented at the time, ‘Historically, Actavis grew by acquisition in other markets, but…
Mr. O’Leary, when an article in The Guardian last year profiled you and your work, it was titled “Resurrecting the Celtic Tiger.” More recently, Time Magazine put Taoiseach Enda Kenny…
To what extent do you believe Ireland has been successful in building the knowledge economy it set out to create during the 1980’s? I think we have been hugely successful—and…
You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business, fueled by blockbuster medicines that met robust medical…
Dr. McLoughlin, you were appointed to your post in April of this year. Can you please give us an impression of what you inherited at this Department when you took…
Dr. Duffy, how has Pfizer’s investment in Ireland evolved over time? Pfizer began operating in Ireland in the late 1960’s, making citric acid which is an ingredient that can be…
Dr. Mitchell, what attracted you to join Novartis after a decades-long career at Astrazeneca? If you had told me a year ago that I would leave the company I’d worked…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two years, what are your…
Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact from research investments.” What do you understand…
Mr. Timmons, when we interviewed your colleague at Takeda Products Ireland, Mr. Kieran Leahy, he mentioned that you have a very interesting professional history. Can you begin by telling us…
Mr. Leahy, you worked for Servier for nearly a decade before joining Takeda. What have been the chief differences you have noticed between the smaller, independent, French player, and the…
With an evident recession and cost-cutting measures abound Ms. Nolan elaborates on the new plain on which pharmaceutical players have found themselves upon and how they have adjusted to the…
Novo Nordisk is primarily known as the premier global diabetes player—so let us begin by examining the realities of diabetes in Ireland. In 2012, the International Diabetes Federation estimated that…
See our Cookie Privacy Policy Here
